Mc Groddy Goetz Kathleen Insider Trades

Insider Trading History

Track insider trading activity for Mc Groddy Goetz Kathleen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $518k 26,612 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$138k 8,759 shares
$15.77
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$138k 8,759 shares
$15.77
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $199k 10,220 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 10,220 shares
$15.04
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $132k 6,812 shares
Last Trade
May 25, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.5k 2,757 shares
$26.29
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $0 0 shares
Last Trade
May 25, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.5k 2,757 shares
$26.29
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $86.2k 4,434 shares
Last Trade
May 24, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$125k 4,434 shares
$28.18
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $23.7k 1,220 shares
Last Trade
Jun 08, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.5k 1,220 shares
$66.02
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $53.6k 2,757 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 2,757 shares
$65.28
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $0 0 shares
Last Trade
May 18, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$145k 2,021 shares
$71.54
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $15.8k 814 shares
Last Trade
Mar 14, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.9k 405 shares
$106.00
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $47.5k 2,440 shares
Last Trade
Jun 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 1,219 shares
$88.83
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $23.7k 1,219 shares
Last Trade
Jun 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 1,219 shares
$88.83
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $39.3k 2,021 shares
Last Trade
May 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 2,021 shares
$81.63
$19.45
Tandem Diabetes Care
Tandem Diabetes Care TNDM
Director
Holding Value $71.2k 3,659 shares
Last Trade
Jun 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 3,659 shares
$81.98
$19.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up